NEW YORK (GenomeWeb) – Roche's plan to take a majority stake in Foundation Medicine sent the cancer molecular diagnostics firm's shares soaring in January, pacing gainers in the GenomeWeb Index for the month. 

Overall, the index rose almost 4 percent month over month, beating the Dow Jones Industrial Average, which fell 4 percent in January, and the Nasdaq, which improved 2 percent. The GenomeWeb Index trailed the Nasdaq Biotech Index, which moved up 6 percent month over month. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.